TY - JOUR
T1 - A male case with CDKL5-associated encephalopathy manifesting transient methylmalonic acidemia
AU - Akamine, Satoshi
AU - Ishizaki, Yoshito
AU - Sakai, Yasunari
AU - Torisu, Hiroyuki
AU - Fukai, Ryoko
AU - Miyake, Noriko
AU - Ohkubo, Kazuhiro
AU - Koga, Hiroshi
AU - Sanefuji, Masafumi
AU - Sakata, Ayumi
AU - Kimura, Masahiko
AU - Yamaguchi, Seiji
AU - Sakamoto, Osamu
AU - Hara, Toshiro
AU - Saitsu, Hirotomo
AU - Matsumoto, Naomichi
AU - Ohga, Shouichi
N1 - Funding Information:
We thank Ryutaro Kira (Fukuoka Children's Hospital) for the long-term management of the patient, and Kazuko Yoshi (Shimane University) for technical assistance. This study was supported by JSPS KAKENHI Grant Number 15K0962 (YS) , a Health and Labour Sciences Research Grant on Evidence-based Early Diagnosis and Treatment Strategies for Neuroimmunological Diseases from the Ministry of Health, Labour and Welfare of Japan, Life Science Foundation of Japan , Takeda Science Foundation , The Mother and Child Health Foundation , The Japan Epilepsy Research Foundation (YS).
Publisher Copyright:
© 2018
PY - 2018/8
Y1 - 2018/8
N2 - Mutations in the X-linked gene CDKL5 cause early-onset epileptic encephalopathy and severe developmental delay. Because this disorder predominantly affects females, the full clinical spectrum of male patients remains elusive. We herein report a 16-year-old boy, who suffered from intractable seizures 20 days after birth. Serial electroencephalograms detected recurrent focal epileptiform discharges from age 4 months, which evolved to hypsarrhythmia later in infancy. Mass-spectrometric analyses revealed increase in urinary excretion of methylmalonic acid without perturbed concentrations of propionic acid, homocystein and methionine. Whole-exome sequencing identified a de novo, truncating mutation in CDKL5 (NM_003159.2:c.419dupA, p.Asn140Lysfs*8). Targeted sequencing excluded concomitant mutations in methylmalonic academia-associated genes. No methylmalonic acidemia has been reported in children with CDKL5 disorder. Extensive analyses on organic acid metabolism for males with CDKL5 mutations will gain more insight into their biochemical profiles in infancy.
AB - Mutations in the X-linked gene CDKL5 cause early-onset epileptic encephalopathy and severe developmental delay. Because this disorder predominantly affects females, the full clinical spectrum of male patients remains elusive. We herein report a 16-year-old boy, who suffered from intractable seizures 20 days after birth. Serial electroencephalograms detected recurrent focal epileptiform discharges from age 4 months, which evolved to hypsarrhythmia later in infancy. Mass-spectrometric analyses revealed increase in urinary excretion of methylmalonic acid without perturbed concentrations of propionic acid, homocystein and methionine. Whole-exome sequencing identified a de novo, truncating mutation in CDKL5 (NM_003159.2:c.419dupA, p.Asn140Lysfs*8). Targeted sequencing excluded concomitant mutations in methylmalonic academia-associated genes. No methylmalonic acidemia has been reported in children with CDKL5 disorder. Extensive analyses on organic acid metabolism for males with CDKL5 mutations will gain more insight into their biochemical profiles in infancy.
UR - http://www.scopus.com/inward/record.url?scp=85043253820&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85043253820&partnerID=8YFLogxK
U2 - 10.1016/j.ejmg.2018.03.003
DO - 10.1016/j.ejmg.2018.03.003
M3 - Article
C2 - 29510241
AN - SCOPUS:85043253820
SN - 1769-7212
VL - 61
SP - 451
EP - 454
JO - European Journal of Medical Genetics
JF - European Journal of Medical Genetics
IS - 8
ER -